Hepatitis E Virus Infection in Patients with Systemic and Cutaneous Lupus Erythematosus
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252011162 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Fulvia Ceccarelli und 13 weiteren Autor:innen. Beteiligte Einrichtung: Lupus Clinic, Rheumatology, Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, 00185 R…. Hauptthemen laut MEDLINE: Hepatitis E, Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences Srl; Ministry of Health, Gilead Sciences Srl, Ministry of Health.
Abstract (Originalsprache)
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by a multifactorial etiology in which genetic and environmental factors interplay. An exclusively cutaneous condition has been described and defined as cutaneous lupus erythematosus (CLE). In Italy, a nationwide blood donor survey found an overall HEV prevalence of 8.7%, with an interregional variation from 2.2% to 22.8%. In this study, we aimed to estimate HEV seroprevalence in a cohort of patients affected by SLE and CLE attending the Lupus Clinic, Sapienza University of Rome. Serum samples were tested for anti-HEV immunoglobulin Ig G and M antibodies using commercial enzyme-linked immunosorbent assay (ELISA) kits. Statistical analysis was performed. In total, 138 patients were enrolled, 92 (67%) affected by SLE and 46 by CLE. The prevalence of HEV infection was 23.9% in the CLE group and 7.6% in the SLE group. The anti-HEV+ prevalence was significantly more frequent in CLE. Some mechanisms may be linked to increased susceptibility to HEV such as a molecular mimicry associated with the CLE condition or with the skin compartment/skin self-antigens, as well as the involvement of the genetic background. Regarding the possible risk factors, no association was found, although, of note, the odds of HEV+ relative to contact with animals and to eating raw seafood were strongly higher than the unit in the CLE group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lupus Clinic, Rheumatology, Dipartimento di Scienze Cliniche, Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma, 00185 Rome, Italy.
- Department of Infectious Diseases, Istituto Superiore di Sanità, 00161 Rome, Italy.
- Institute of Public Health (ISHP), 1001 Tirana, Albania.
- Department of Tropical and Infectious Diseases, Aou Policlinico Umberto I, 00161 Rome, Italy.
- Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, 00128 Rome, Italy.
ORCID-Profile: Roberto Bruni, Umbertina Villano, Massimo Ciccozzi, Alessandra Lo Presti
Förderung
- Gilead Sciences Srl; Ministry of Health
- Gilead Sciences Srl
- Ministry of Health
Zitieren
APA
Ceccarelli, F., Dorrucci, M., Pirone, C., Mataj, E., Garufi, C., Farchi, F., Bruni, R., Villano, U., Madonna, E., Iaiani, G., Ciccozzi, M., Ciccaglione, A. R., Conti, F., & Lo Presti, A. (2024). Hepatitis E Virus Infection in Patients with Systemic and Cutaneous Lupus Erythematosus. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252011162
Vancouver
Ceccarelli F, Dorrucci M, Pirone C, Mataj E, Garufi C, Farchi F, et al. Hepatitis E Virus Infection in Patients with Systemic and Cutaneous Lupus Erythematosus. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252011162
BibTeX
@article{Ceccarelli2024,
author = {Ceccarelli, Fulvia and Dorrucci, Maria and Pirone, Carmelo and Mataj, Elida and Garufi, Cristina and Farchi, Francesca and Bruni, Roberto and Villano, Umbertina and Madonna, Elisabetta and Iaiani, Giancarlo and Ciccozzi, Massimo and Ciccaglione, Anna Rita and Conti, Fabrizio and Lo Presti, Alessandra},
title = {Hepatitis E Virus Infection in Patients with Systemic and Cutaneous Lupus Erythematosus},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252011162}
}
EUVIMED